Rising Tide: Amniotic Tissue Treatments for Diabetic Foot Ulcers
This study, called "Rising Tide," is looking at new ways to treat chronic diabetic foot ulcers (DFUs). Researchers are testing different types of placental-based allografts (tissue from a donor, in this case, from the placenta) called Amnion/Chorion/Amnion, Amnion/Chorion, and Amnion/Amnion. These treatments will be given along with standard care, and compared to standard care alone. The main goal is to see how many DFUs heal after 12 weeks of treatment. You might be able to join if you are at least 18 years old and have a DFU that meets specific criteria. The study plans to enroll 240 people, but its current status is unclear.
- Study design
- This interventional study plans to enroll 240 participants. It compares different placental-based allografts plus standard care to standard care alone.
- What's involved
- Not specified in the trial record.
- Compensation
- Not stated in the trial record.
- Follow-up
- The primary endpoint is measured at 12 weeks, indicating follow-up for at least this duration.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Rising Tide - Amniotic Tissue(s) Treatments for Chronic Diabetic Foot Ulcers
At a glance
Conditions
Where it's being run
9 sites across 5 statesStudy leadership
- David G Armstrong, DPM, MD, PhD · STUDY_CHAIR · Keck School of Medicine of USC
- Frank Burrows, MBA, EMT, BCMAS, CWCA · STUDY_DIRECTOR · Tides Medical
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
What this trial measures
- Percentage of DFUs healed at 12 weeks12 Weeks
Percentage of index ulcers (the ulcers being treated in the study) healed at 12 weeks